Flounder Biotech enters into a licensing agreement with Pang Pharmaceutical for a drug under development. Flounder will receive a payment of $7,700,000 if the drug receives regulatory approval. Based on prior experience in the drug-approval process, Flounder determines it is 80% likely that the drug will gain approval and a 20% chance of denial.

Determine the transaction price of the arrangement for Flounder Biotech.

Transaction price

$

eTextbook and Media

List of Accounts

Assuming that regulatory approval was granted on December 20, 2020, and that Flounder received the payment from Pang on January 15, 2021, prepare the journal entries for Flounder. The license meets the criteria for point-in-time revenue recognition. (Credit account titles are automatically indented when the amount is entered. Do not indent manually. If no entry is required, select "No entry" for the account titles and enter 0 for the amounts.)

Date	Account Titles and Explanation	Debit	Credit
Dec. 20, 2020Jan. 15, 2021
Dec. 20, 2020Jan. 15, 2021

show work and explain